Skip to main content

Table 2 Dose-response association between blood lipids and the risk of DKD

From: Are blood lipids associated with microvascular complications among type 2 diabetes mellitus patients? A cross-sectional study in Shanghai, China

Exposure Variables TG HDL-C TG/HDL-C Non-HDL-C/HDL-C
OR (95%CI) P OR (95%CI) P OR (95%CI) P OR (95%CI) P
Total
 Turning point 1.90 mmol/L   1.62 mmol/L   2.00   3.09  
 Lower than turning point 1.48(1.21–1.81) < 0.001 0.42(0.31–0.58) < 0.001 1.52(1.30–1.78) < 0.001 1.34(1.17–1.53) < 0.001
 Higher than turning point 0.99(0.89–1.09) 0.793 1.68(0.95–2.95) 0.074 0.95(0.87–1.05) 0.316 0.97(0.85–1.10) 0.603
Men
 Turning point   1.62 mmol/L   1.96   3.07  
 Lower than turning point 0.43(0.27–0.70) 0.001 1.51(1.18–1.95) 0.001 1.40(1.13–1.73) 0.002
 Higher than turning point 1.15(0.41–3.21) 0.789 0.98(0.87–1.10) 0.715 1.01(0.84–1.22) 0.932
Women
 Turning point   1.61 mmol/L   2.09   2.63  
 Lower than turning point 0.43(0.28–0.68) < 0.001 1.59(1.29–1.94) < 0.001 1.45(1.14–1.85) 0.003
 Higher than turning point 1.72(0.87–3.39) 0.120 0.88(0.76–1.03) 0.119 0.97(0.84–1.11) 0.620
  1. Adjusted for age, sex, family history of diabetes mellitus, duration of diabetes mellitus, current medical treatment, smoke status, comorbid hypertension, comorbid CAD, comorbid stroke, BMI, HbA1c, SBP